MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Alexion Pharmaceuticals Company Profile (NASDAQ:ALXN)

Consensus Ratings for Alexion Pharmaceuticals (NASDAQ:ALXN) (?)
Ratings Breakdown: 5 Hold Rating(s), 12 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $221.07 (12.94% upside)

Current Analysts' Coverage Summary for Alexion Pharmaceuticals (NASDAQ:ALXN)
Show:
DateFirmActionRatingPrice TargetActions
7/31/2015Stifel NicolausBoost Price TargetBuy$239.00 -> $257.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Brean CapitalReiterated RatingBuy$213.00 -> $221.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015JPMorgan Chase & Co.Initiated CoverageOverweight$249.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2015Piper JaffrayReiterated RatingBuy$235.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2015Goldman SachsBoost Price TargetNeutral$200.00 -> $202.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015BarclaysReiterated RatingOverweight$205.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2015Sanford C. BernsteinSet Price TargetBuy$267.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015Leerink SwannReiterated RatingOutperform$224.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Morgan StanleyReiterated RatingEqual Weight$185.00 -> $177.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2015SunTrustReiterated RatingBuy$236.00 -> $246.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Citigroup Inc.Set Price TargetHold$208.00 -> $173.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015NomuraUpgradeNeutral -> Buy$222.00 -> $246.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015OppenheimerInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Jefferies GroupBoost Price TargetHold$164.00 -> $167.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2015BTIG ResearchReiterated RatingBuy$250.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2014Bank of AmericaInitiated CoverageBuy$197.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014Credit SuisseInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2014Robert W. BairdBoost Price Target$175.00 -> $199.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2014Deutsche BankBoost Price TargetBuy$125.00 -> $205.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2014Canaccord GenuityBoost Price TargetBuy$161.00 -> $200.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/25/2013GuggenheimBoost Price TargetBuy$127.00 -> $130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/25/2013Cowen and CompanyBoost Price TargetOutperform$115.00 -> $123.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/3/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha